查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726210

C反應蛋白檢測市場規模、佔有率、趨勢分析報告（按檢測類型、檢測範圍、疾病區域、最終用途、地區和細分市場預測），2025-2030年

C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type (ELISA, CLIA), By Detection Range (hs-CRP, Conventional CRP), By Disease Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10個工作天內

價格

C反應蛋白檢測市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球C反應蛋白（CRP）檢測市場規模預計到2030年將達到56.6億美元，2025年至2030年期間的複合年成長率為0.24%。

C反應蛋白檢測的成長得益於旨在探索此檢測各種應用的大量研究活動。私人和公共組織提供資金來促進這一領域的研究，進一步推動了這項研究活動。由於奈米技術工具的進步，市場預計將顯著成長。這些進步為開發可攜式生物分析檢測方法提供了良好的機會，這些檢測方法具有高特異性、靈敏度、快速反應時間和連接複用能力等特性，可以在照護端進行準確的疾病診斷和監測。

預計這些進步將在預測期內推動 CRP 測試的需求。此外，策略交易和發展的增加以及研發投資的增加也推動了成長。由於 CRP 被認為是評估感染和發炎嚴重程度的重要生物標記物，因此 COVID-19 大流行對市場產生了相當大的影響。這導致對服務和產品的需求增加。雅培等主要企業正在提供針對 SARS-CoV-2 感染的特定 CRP 檢測的支援工具，進一步促進了市場的成長。此外，主要企業越來越關注產品發布和照護現場CRP 測試的開發，預計這將在未來幾年進一步推動市場成長。

例如，2022 年 7 月，Bloom Diagnostics 推出了 Bloom 發炎測試，這是一種旨在量化血液中 CRP 水平的半自動化檢測套組。此一次性試劑套件有助於檢測體內的發炎。預計測試設施的建立將進一步刺激市場成長。 2021 年 6 月，Trivitron 醫療保健推出了用於診斷 COVID-19 的行動偵測實驗室，為印度各地（包括農村、都市區和偏遠地區）提供檢測服務。這個獨特的實驗室提供各種測試，包括針對 CRP、IL-6 和 D-二聚體等發炎標記物的 CLIA/Elisa 測試、快速抗原測試、RT-PCR 測試以及 CLIA/Elisa 抗體測試 IgM 和 IgG。

2022 年，北美佔據了最大的收益佔有率，為 39.42%，並且由於心血管疾病患病率的不斷上升、產品穩步推出、現有市場參與企業的存在、技術進步以及發達的醫療保健基礎設施，預計在預測期內將保持其佔有率。預計 2023 年至 2030 年間，亞太地區的複合年成長率最快，為 0.49%。 COVID-19 疫情起源於中國。 CRP 測試（一種用於確定感染嚴重程度的潛在生物標記）的需求預計很快就會增加。全球產業主要企業不斷注重產品發布和地理擴張以保持其地位。

C反應蛋白檢測市場報告重點

  • 根據檢測類型，免疫比濁法測定部分在 2024 年佔據了最大的收益佔有率，為 48.5%。隨著高靈敏度、自動化、經濟高效的免疫比濁法測定的推出，該測定方法提供了廣泛的測量範圍，可以準確檢測樣品中的 CRP 水平。
  • 以檢測範圍計算，hs-CRP 細分市場在 2024 年佔據市場主導地位，收益佔有率約為 42.80%。 hs-CRP比傳統CRP有更廣的檢測範圍。
  • 根據治療領域，心血管疾病領域預計將在 2024 年佔據最大的市場佔有率，並在整個預測期內佔據市場主導地位。心血管疾病 (CVD) 盛行率的不斷上升是推動 CRP 檢測市場成長的主要因素。
  • 2024 年，醫院終端用戶部門佔據了 28.0% 的市場佔有率，這得益於醫院對 CRP 檢測的採用率增加，尤其是為了應對 COVID-19 疫情。這提高了測試率，促進了該領域的成長。
  • 此外，由於慢性心臟疾病和癌症的發生率不斷上升，市場也不斷成長。由於在診斷、管理和監測這些疾病方面對 CRP 檢測的需求不斷增加，這些疾病對市場擴張做出了重大貢獻。

目錄

第1章調查方法與範圍

第2章執行摘要

3. C反應蛋白檢測市場變數、趨勢和範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • C反應蛋白檢測市場分析工具
    • 波特五力分析
    • PESTEL分析

4. C反應蛋白檢測市場（依檢測類型、估值和趨勢分析）

  • C反應蛋白檢測市場：檢測類型變異分析
  • 免疫比濁法
    • 免疫比濁法市場，2018-2030
  • ELISA
    • ELISA 市場，2018-2030 年
    • 臨床ELISA
    • 非臨床 ELISA
  • 化學冷光免疫檢測
    • 化學冷光免疫檢測市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第5章 C反應蛋白檢測市場：依檢測範圍的估計與趨勢分析

  • C反應蛋白檢測市場：檢測範圍變化分析
  • 高敏感性C反應蛋白（hs-CRP）
    • 高敏感性C反應蛋白（hs-CRP）市場，2018-2030
  • 常規 CRP
    • 傳統CRP市場，2018-2030
  • 心臟C反應蛋白（cCRP）
    • 心臟 CRP (cCRP) 市場，2018-2030 年

6. C反應蛋白檢測市場：依疾病領域估計與趨勢分析

  • C反應蛋白檢測市場：疾病區域變異分析
  • 心血管疾病
    • 2018-2030年心血管疾病市場
  • 癌症
    • 癌症市場，2018-2030
  • 類風濕性關節炎
    • 類風濕性關節炎市場，2018-2030
  • 發炎性腸道疾病
    • 發炎性腸道疾病市場，2018-2030
  • 子宮內膜異位症
    • 子宮內膜異位症市場，2018-2030
  • 狼瘡
    • 狼瘡市場，2018-2030
  • 其他
    • 其他市場，2018-2030

7. C反應蛋白檢測市場最終用途、估價及趨勢分析

  • C反應蛋白檢測市場：最終用途變異分析
  • 診所
    • 診所市場，2018-2030
    • 診所和團體
    • 按診所和環境
  • 醫院
    • 醫院市場，2018-2030
    • 都市環境
    • 當地環境
  • 實驗室
    • 實驗室市場，2018-2030
    • 都市環境
    • 當地環境
  • 護理設施
    • 輔助生活市場，2018-2030
    • 都市環境
    • 當地環境
  • 住宅
    • 2018-2030年住宅市場
  • 其他
    • 其他市場，2018-2030

8. C反應蛋白檢測市場：區域、估計和趨勢分析

  • C反應蛋白檢測市場佔有率（2024年及2030年，百萬美元）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
  • Abbott
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Siemens Healthineers AG
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Danaher Corporation
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Quest Diagnostics
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Siemens Healthineers AG
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Abbott
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Merck KGaAA
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Zoetis
    • 參與企業概況
    • 近期趨勢/策略舉措
  • F. Hoffmann-La Roche AG
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Ortho Clinical Diagnostics
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Thermo Fisher Scientific, Inc.
    • 參與企業概況
    • 近期趨勢/策略舉措
  • HORIBA, Ltd
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Randox Laboratories Ltd.
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Boditech Med, Inc.
    • 參與企業概況
    • 近期趨勢/策略舉措
  • Aidian
    • 參與企業概況
    • 近期趨勢/策略舉措
Product Code: GVR-2-68038-129-0

C-Reactive Protein Testing Market Growth & Trends:

The global C-reactive protein testing market size is expected to reach USD 5.66 billion by 2030 and is projected to grow at a CAGR of 0.24% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of C-reactive protein (CRP) testing can be attributed to significant research activities aimed at exploring various applications of testing. These research efforts are further facilitated by the presence of both private and public agencies that provide funding to expedite research in this field. The market is anticipated to witness significant growth owing to advancements in nanotechnological tools. These advancements offer promising opportunities to develop portable bioanalytical assays that possess attributes, such as high specificity, sensitivity, rapid response time, and the ability to perform multiplexing for accurate disease diagnosis and monitoring at the point of care.

These advancements are expected to drive the demand for CRP testing during the forecast period. Furthermore, an increase in strategic deals and developments, as well as higher investments in research and development has fueled the growth. The COVID-19 pandemic has had a considerable impact on the market, as CRP is considered a crucial biomarker for assessing the severity of infection and inflammation. As a result, there is an increased demand for services and products. Leading companies, such as Abbott, provide supportive tools for CRP testing specifically for SARS-CoV-2 infection, further contributing to market growth. Moreover, key players increased focus on product launches and developments in point-of-care CRP tests, which is projected to further fuel the market's growth in the coming years.

For instance, in July 2022, Bloom Diagnostics introduced the Bloom Inflammation Test, a semi-automated testing kit designed for the quantification of CRP levels in the blood. This single-use kit aids in the detection of inflammation within the body. The growth of the marketplace is expected to be further stimulated by the establishment of testing facilities. In June 2021, Trivitron Healthcare unveiled a mobile laboratory for COVID-19 diagnostics, enabling testing services in various regions of India, including rural, urban, and remote areas. This indigenous laboratory offers a range of tests, including CLIA/Elisa tests for inflammatory markers, such as a CRP, IL-6, and D-Dimer, as well as rapid antigen tests, RT-PCR tests, CLIA/Elisa Antibodies Tests IgM and IgG, and others.

North America held the largest revenue share of 39.42% in 2022 and is expected to maintain its share during the forecast period due to the increasing prevalence of cardiovascular diseases, a steady stream of product launches, presence of established market players, technological advancements, and well-developed healthcare infrastructure. Asia Pacific is projected to grow at the fastest CAGR of 0.49% from 2023 to 2030. The COVID-19 pandemic originated in China. Being the potential biomarker for determining the severity of the infection, the demand for CRP testing is expected to increase shortly. Key players operating in the global industry are constantly focusing on product launches and geographical expansion to maintain their presence.

C-Reactive Protein Testing Market Report Highlights:

  • Based on assay type, the immunoturbidimetric assay segment held the largest revenue share of 48.5% in 2024. Owing to the introduction of a highly sensitive, automated, and cost-effective immunoturbidimetric assay that offers a wide measuring range for accurately detecting the levels of CRP in samples
  • Based on detection ranges, the hs-CRP segment dominated the market in 2024 with a revenue share of approximately 42.80%. The hs-CRP features a broad detection range than that compared to the conventional CRP
  • Based on disease area type, the cardiovascular diseases segment dominated the market with the largest market share in 2024 and is anticipated to dominate the market throughout the forecast period. The increase in the prevalence of CVDs is the major factor contributing to the growth of the CRP testing market
  • The hospitals end-user segment dominated with a market share of 28.0% in 2024 due to the increased adoption of CRP testing in hospitals, particularly in response to the COVID-19 pandemic. This has led to a higher testing rate and contributed to the segment's growth
  • Furthermore, the marketplace is experiencing growth due to the increasing prevalence of chronic heart diseases and cancers. These conditions contribute significantly to the market's expansion as there is a rising demand for CRP testing in the diagnosis, management, and monitoring of these diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Assay Type
    • 1.2.2. Detection Range
    • 1.2.3. Disease Type
    • 1.2.4. End Use
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. C-Reactive Protein Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising incidence of chronic and infectious diseases
      • 3.3.1.2. Increasing demand for point-of-care diagnostics
      • 3.3.1.3. Growing demand for portable and automated C-reactive proteins
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Lower detection limit
      • 3.3.2.2. Limitations associated with C-reactive protein techniques
  • 3.4. C-Reactive Protein Testing Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. C-Reactive Protein Testing Market: Assay Type Estimates & Trend Analysis

  • 4.1. C-reactive Protein (CRP) Testing Market: Assay Type Movement Analysis
  • 4.2. Immunoturbidimetric Assay
    • 4.2.1. Immunoturbidimetric Assay Market, 2018 - 2030 (USD Million)
  • 4.3. ELISA
    • 4.3.1. ELISA Market, 2018 - 2030 (USD Million)
    • 4.3.2. Clinical ELISA
      • 4.3.2.1. Clinical ELISA Market, 2018 - 2030 (USD Million)
    • 4.3.3. Nonclinical ELISA
      • 4.3.3.1. Nonclinical ELISA Market, 2018 - 2030 (USD Million)
  • 4.4. Chemiluminescence Immunoassay
    • 4.4.1. Chemiluminescence Immunoassay Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. C-Reactive Protein Testing Market: Detection Range Estimates & Trend Analysis

  • 5.1. C-reactive Protein (CRP) Testing Market: Detection Range Movement Analysis
  • 5.2. High Sensitivity C-reactive Protein (hs-CRP)
    • 5.2.1. High Sensitivity C-reactive Protein (hs-CRP) Market, 2018 - 2030 (USD Million)
  • 5.3. Conventional CRP
    • 5.3.1. Conventional CRP Market, 2018 - 2030 (USD Million)
  • 5.4. Cardiac CRP (cCRP)
    • 5.4.1. Cardiac CRP (CCRP) Market, 2018 - 2030 (USD Million)

Chapter 6. C-Reactive Protein Testing Market Disease Area Estimates & Trend Analysis

  • 6.1. C-reactive Protein (CRP) Testing Market: Disease Area Movement Analysis
  • 6.2. Cardiovascular Diseases
    • 6.2.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
  • 6.3. Cancer
    • 6.3.1. Cancer Market, 2018 - 2030 (USD Million)
  • 6.4. Rheumatoid Arthritis
    • 6.4.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
  • 6.5. Inflammatory Bowel Disease
    • 6.5.1. Inflammatory Bowel Disease Market, 2018 - 2030 (USD Million)
  • 6.6. Endometriosis
    • 6.6.1. Endometriosis Market, 2018 - 2030 (USD Million)
  • 6.7. Lupus
    • 6.7.1. Lupus Market, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. C-Reactive Protein Testing Market End Use Estimates & Trend Analysis

  • 7.1. C-reactive Protein (CRP) Testing Market: End-use Movement Analysis
  • 7.2. Clinics
    • 7.2.1. Clinics Market, 2018 - 2030 (USD Million)
    • 7.2.2. Clinics, by entity
      • 7.2.2.1. Physician offices
        • 7.2.2.1.1. Physician Offices Market, 2018 - 2030 (USD Million)
      • 7.2.2.2. Small clinics
        • 7.2.2.2.1. Small Clinics Market, 2018 - 2030 (USD Million)
      • 7.2.2.3. Others
        • 7.2.2.3.1. Others Market, 2018 - 2030 (USD Million)
    • 7.2.3. Clinics, by setting
      • 7.2.3.1. Urban setting
        • 7.2.3.1.1. Urban Setting Market, 2018 - 2030 (USD Million)
      • 7.2.3.2. Rural settings
        • 7.2.3.2.1. Rural Settings Market, 2018 - 2030 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market, 2018 - 2030 (USD Million)
    • 7.3.2. Urban setting
      • 7.3.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
    • 7.3.3. Rural settings
      • 7.3.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
  • 7.4. Laboratories
    • 7.4.1. Laboratories Market, 2018 - 2030 (USD Million)
    • 7.4.2. Urban setting
      • 7.4.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
    • 7.4.3. Rural settings
      • 7.4.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
  • 7.5. Assisted Living Healthcare Facilities
    • 7.5.1. Assisted Living Healthcare Facilities Market, 2018 - 2030 (USD Million)
    • 7.5.2. Urban setting
      • 7.5.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
    • 7.5.3. Rural settings
      • 7.5.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
  • 7.6. Home
    • 7.6.1. Home Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. C-Reactive Protein Testing Market: Regional Estimates & Trend Analysis

  • 8.1. C-Reactive Protein Testing Market Share, By Region, 2024 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. Reimbursement Scenario
      • 8.2.2.6. U.S. C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. Canada C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Mexico C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. Reimbursement Scenario
      • 8.3.2.6. UK C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. France C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. Italy C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Spain C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Denmark C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Sweden C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Norway C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. Australia C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. South Korea C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Thailand C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Reimbursement Scenario
      • 8.5.2.6. Brazil C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Argentina C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Reimbursement Scenario
      • 8.6.2.6. South Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. Saudi Arabia C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. UAE C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. Kuwait C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
  • 9.5. Abbott
    • 9.5.1. Participant's Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Developments/ Strategic Initiatives
  • 9.6. Siemens Healthineers AG
    • 9.6.1. Participant's Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Developments/ Strategic Initiatives
  • 9.7. Danaher Corporation
    • 9.7.1. Participant's Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Developments/ Strategic Initiatives
  • 9.8. Quest Diagnostics
    • 9.8.1. Participant's Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Developments/ Strategic Initiatives
  • 9.9. Siemens Healthineers AG
    • 9.9.1. Participant's Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Developments/ Strategic Initiatives
  • 9.10. Abbott
    • 9.10.1. Participant's Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Developments/ Strategic Initiatives
  • 9.11. Merck KGaAA
    • 9.11.1. Participant's Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Developments/ Strategic Initiatives
  • 9.12. Zoetis
    • 9.12.1. Participant's Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Developments/ Strategic Initiatives
  • 9.13. F. Hoffmann-La Roche AG
    • 9.13.1. Participant's Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Developments/ Strategic Initiatives
  • 9.14. Ortho Clinical Diagnostics
    • 9.14.1. Participant's Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Developments/ Strategic Initiatives
  • 9.15. Thermo Fisher Scientific, Inc.
    • 9.15.1. Participant's Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Developments/ Strategic Initiatives
  • 9.16. HORIBA, Ltd
    • 9.16.1. Participant's Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Developments/ Strategic Initiatives
  • 9.17. Randox Laboratories Ltd.
    • 9.17.1. Participant's Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Developments/ Strategic Initiatives
  • 9.18. Boditech Med, Inc.
    • 9.18.1. Participant's Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Developments/ Strategic Initiatives
  • 9.19. Aidian
    • 9.19.1. Participant's Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global C-reactive protein market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 4 Global C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 5 Global C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 6 Global C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 9 North America C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 10 North America C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 11 North America C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 13 U.S. C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 14 U.S. C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 15 U.S. C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 17 Canada C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 18 Canada C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 19 Canada C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Mexico C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 21 Mexico C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Mexico C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 23 Mexico C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 26 Europe C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 27 Europe C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 28 Europe C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 30 UK C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 31 UK C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 32 UK C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Germany C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 34 Germany C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 35 Germany C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 36 Germany C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 France C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 38 France C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 39 France C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 40 France C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Italy C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 42 Italy C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 43 Italy C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 44 Italy C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Spain C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 46 Spain C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 47 Spain C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 48 Spain C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Denmark C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 50 Denmark C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 51 Denmark C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 52 Denmark C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Sweden C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 54 Sweden C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 55 Sweden C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 56 Sweden C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Norway C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 58 Norway C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 59 Norway C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 60 Norway C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Japan C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 67 Japan C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 68 Japan C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 69 Japan C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 China C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 71 China C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 72 China C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 73 China C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 India C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 75 India C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 76 India C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 77 India C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Australia C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 79 Australia C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 80 Australia C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 81 Australia C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Korea C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 83 South Korea C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 84 South Korea C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 85 South Korea C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Thailand C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 87 Thailand C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 88 Thailand C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 89 Thailand C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Latin America C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 92 Latin America C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 93 Latin America C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 94 Latin America C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Brazil C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 96 Brazil C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 97 Brazil C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 98 Brazil C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 100 Argentina C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 101 Argentina C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 102 Argentina C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 105 MEA C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 106 MEA C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 107 MEA C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 109 South Africa C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 110 South Africa C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 111 South Africa C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 117 UAE C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 118 UAE C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 119 UAE C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 123 Kuwait C-reactive protein market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 C-reactive protein testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 C-reactive protein testing market: Assay type outlook key takeaways
  • Fig. 20 C-reactive protein testing market: Assay type movement analysis
  • Fig. 21 Immunoturbidimetric assay market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 22 ELISA market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 23 Chemiluminescence Immunoassay (CLIA ) market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 24 Other Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 25 C-reactive protein market: Detection Range outlook key takeaways
  • Fig. 26 C-reactive protein market: Detection Range movement analysis
  • Fig. 27 hs-CRP market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 28 Conventional CRP market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 29 cCRP market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 30 C-reactive protein market: Disease Type outlook key takeaways
  • Fig. 31 C-reactive protein market: Disease Type movement analysis
  • Fig. 32 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 33 Cancer market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 34 Rheumatoid arthritis market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 35 Inflammatory bowel disease Testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 36 Endometriosis market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 37 Lupus market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 39 C-reactive protein market: End-use outlook key takeaways
  • Fig. 40 C-reactive protein market: End-use movement analysis
  • Fig. 41 Hospitals market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 42 Clinics market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 43 Physician Office clinics market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 44 Small clinics market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 45 Others clinics market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 46 Laboratories market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 47 Assisted living healthcare facilities market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 48 Home market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 50 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 53 Key country dynamics
  • Fig. 54 U.S. C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Canada C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Mexico C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 59 Europe C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 60 Key country dynamics
  • Fig. 61 UK C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Germany C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 64 Key country dynamics
  • Fig. 65 France C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Spain C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Denmark C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Sweden C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Norway C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 76 Asia Pacific C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Japan C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 79 Key country dynamics
  • Fig. 80 China C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 81 Key country dynamics
  • Fig. 82 India C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Australia C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Korea C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Thailand C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Market participant categorization
  • Fig. 91 C-reactive protein testing market position analysis, 2023
  • Fig. 92 Strategic framework